Abstract
Original language | English |
---|---|
Article number | 100665 |
Number of pages | 13 |
Journal | The Lancet Healthy Longevity |
Volume | 5 |
Issue number | 12 |
DOIs | |
Publication status | Published - 1 Dec 2024 |
Access to Document
Fingerprint
Dive into the research topics of 'Next generation brain health: transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet Healthy Longevity, Vol. 5, No. 12, 100665, 01.12.2024.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Next generation brain health
T2 - transforming global research and public health to promote prevention of dementia and reduce its risk in young adult populations
AU - Farina, Francesca R.
AU - Bridgeman, Katie
AU - Gregory, Sarah
AU - Crivelli, Lucía
AU - Foote, Isabelle F.
AU - Jutila, Otto Emil I.
AU - Kucikova, Ludmila
AU - Mariano, Luciano I.
AU - Nguyen, Kim Huong
AU - Thayanandan, Tony
AU - Akindejoye, Funmi
AU - Butler, Joe
AU - Calandri, Ismael L.
AU - Cepukaityte, Giedre
AU - Chiesa, Scott T.
AU - Dawson, Walter D.
AU - Deckers, Kay
AU - Cruz-Góngora, Vanessa De la
AU - Dounavi, Maria Eleni
AU - Govia, Ishtar
AU - Guzmán-Vélez, Edmarie
AU - Heikal, Shimaa A.
AU - Hill-Jarrett, Tanisha G.
AU - Ibáñez, Agustín
AU - James, Bryan D.
AU - McGlinchey, Eimear
AU - Mullin, Donncha S.
AU - Muniz-Terrera, Graciela
AU - Pintado Caipa, Maritza
AU - Qansuwa, Esraa M.
AU - Robinson, Louise
AU - Santuccione Chadha, Antonella
AU - Shannon, Oliver M.
AU - Su, Li
AU - Weidner, Wendy
AU - Booi, Laura
N1 - Funding Information: FRF is supported by Alzheimer's Association (AARF-21-848281) and GBHI, Trinity College Dublin (GBHI ALZ UK-22-863168). KD is supported by the Netherlands Dementia Prevention Initiative funded by the Dutch Medical Research Council (ZonMw) as part of the National Dementia Strategy 2021\u201330 by the Dutch Ministry of Health, Wellbeing and Sport (1051003210004). M-ED is supported by Alzheimer's Society UK (612). STC is supported by an Alzheimer's Research UK David Carr Fellowship (ARUK-RF2021B-006). JB is supported by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration for the North East and North Cumbria (NIHR200173). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care, UK. IFF is supported by NIA (RF1AG073593). EG-V is supported by NIA (K23AG061276) and Alzheimer's Association. O-EIJ is supported by Precision Medicine Grant (2016-21); MR/N013166/1. LR is supported by NIHR, Economic and Social Research Council, and Alzheimer's Society; she has also received honorarium from Eli Lilly for educational resources. DSM is supported by the Scottish Clinical Research Excellence Development Scheme and is a member of the Alzheimer Scotland Dementia Research Centre, funded by Alzheimer Scotland. LS is supported by an Alzheimer's Research UK Senior Research Fellowship (ARUK-SRF2017B-1) and the NIHR Sheffield Biomedical Research Centre (NIHR203321). AI is partially supported by ANID/FONDECYT Regular (1210195, 1210176, and 1220995); ANID/FONDAP/15150012; ANID/PIA/ANILLOS ACT210096; FONDEF ID20I10152; ANID/FONDAP 15150012; Takeda CW2680521; and the multi-partner consortium to expand dementia research in Latin America (ReD-Lat, supported by Fogarty International and National Institutes of Health, NIA [R01 AG057234, R01 AG075775, R01 AG021051, CARDS-NIH], Alzheimer's Association [SG-20-725707], Rainwater Charitable Foundation [Tau Consortium], the Bluefield Project to Cure Frontotemporal Dementia, and GBHI). BDJ is supported by R01AG072559, P30AG072975, and R01NS131433. LK is a recipient of the Flagship Scholarship from the University of Sheffield and received travel support from Alzheimer's Association for the Alzheimer's Association International Conference 2023 at which this roundtable took place. GC is supported by a UK Dementia Research Institute Grand Challenge Award. EMQ is supported by GBHI and Alzheimer's Association. WDD is partially supported by grants and contracts from BrainLat (BL-SRGP2021-03); GBHI and Alzheimer's Association (GBHI ALZ UK-20-640170); American Nurses Foundation; NIA (NIA P30 AG024978-18); Oregon Health Authority (interagency agreements 171319, 18151, 181488, and 179517); Better with Age Initiative of the Portland State University Foundation and Health Resources and Services Administration (U1Q53044), unrelated to this work. WDD reports honoraria from GBHI and a leadership role with the Global Observatory of Long-Term Care, unrelated to this work. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Funding Information: FRF is supported by Alzheimer\u2019s Association ( AARF-21-848281 ) and GBHI, Trinity College Dublin ( GBHI ALZ UK-22-863168 ). KD is supported by the Netherlands Dementia Prevention Initiative funded by the Dutch Medical Research Council (ZonMw) as part of the National Dementia Strategy 2021\u201330 by the Dutch Ministry of Health, Wellbeing and Sport (1051003210004). MD is supported by Alzheimer's Society UK ( 612 ). STC is supported by an Alzheimer\u2019s Research UK David Carr Fellowship ( ARUK-RF2021B-006 ). JB is supported by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration for the North East and North Cumbria ( NIHR200173 ). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. IFF is supported by NIA (RF1AG073593). EG is supported by NIA (K23AG061276) and Alzheimer\u2019s Association. OIJ is supported by Precision Medicine Grant [2016-2021] - MR/N013166/1. LR is supported by NIHR, Economic and Social Research Council, and Alzheimer\u2019s Society; she has also received honorarium from Eli Lilly for educational resources. DSM is supported by the Scottish Clinical Research Excellence Development Scheme and is a member of the Alzheimer Scotland Dementia Research Centre, funded by Alzheimer Scotland. LS is supported by an Alzheimer's Research UK Senior Research Fellowship (ARUK-SRF2017B-1) and the NIHR Sheffield Biomedical Research Centre (NIHR203321). AI is partially supported by ANID/FONDECYT Regular (1210195, 1210176, and 1220995); ANID/FONDAP/15150012; ANID/PIA/ANILLOS ACT210096; FONDEF ID20I10152; ANID/FONDAP 15150012; Takeda CW2680521; and the multi-partner consortium to expand dementia research in Latin America [ReD-Lat, supported by Fogarty International and National Institutes of Health, NIA (R01 AG057234, R01 AG075775, R01 AG021051, CARDS-NIH), Alzheimer\u2019s Association (SG-20-725707), Rainwater Charitable foundation \u2013 Tau Consortium, the Bluefield Project to Cure Frontotemporal Dementia, and GBHI)]. BDJ is supported by R01AG072559, P30AG072975, and R01NS131433. LK is a recipient of the Flagship Scholarship from the University of Sheffield and received travel support from Alzheimer's Association for the Alzheimer's Association International Conference 2023 at which this roundtable took place. GC is supported by a UK Dementia Research Institute Grand Challenge Award. EMQ is supported by GBHI and Alzheimer\u2019s Association. WDD is partially supported by grants and contracts from BrainLat (BL-SRGP2021-03); GBHI and Alzheimer\u2019s Association (GBHI ALZ UK-20-640170); American Nurses Foundation; NIA (NIA P30 AG024978-18); Oregon Health Authority (interagency agreements 171319, 18151, 181488, and 179517); Better with Age Initiative of the Portland State University Foundation; Health Resources and Services Administration (U1Q53044), unrelated to this work. WDD reports honoraria from GBHI and a leadership role with the Global Observatory of Long-Term Care, unrelated to this work. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Publisher Copyright: © 2024 The Author(s)
PY - 2024/12/1
Y1 - 2024/12/1
N2 - Efforts to prevent dementia can benefit from precision interventions delivered to the right population at the right time; that is, when the potential to reduce risk is the highest. Young adults (aged 18–39 years) are a neglected population in dementia research and policy making despite being highly exposed to several known modifiable risk factors. The risk and protective factors that have the biggest effect on dementia outcomes in young adulthood, and how these associations differ across regions and groups, still remain unclear. To address these uncertainties, the Next Generation Brain Health team convened a multidisciplinary expert group representing 15 nations across six continents. We identified several high-priority modifiable factors in young adulthood and devised five key recommendations for promoting brain health, ranging from individual to policy levels. Increasing research and policy focus on brain health across the life course, inclusive of younger populations, is the next crucial step in the efforts to prevent dementia at the global level.
AB - Efforts to prevent dementia can benefit from precision interventions delivered to the right population at the right time; that is, when the potential to reduce risk is the highest. Young adults (aged 18–39 years) are a neglected population in dementia research and policy making despite being highly exposed to several known modifiable risk factors. The risk and protective factors that have the biggest effect on dementia outcomes in young adulthood, and how these associations differ across regions and groups, still remain unclear. To address these uncertainties, the Next Generation Brain Health team convened a multidisciplinary expert group representing 15 nations across six continents. We identified several high-priority modifiable factors in young adulthood and devised five key recommendations for promoting brain health, ranging from individual to policy levels. Increasing research and policy focus on brain health across the life course, inclusive of younger populations, is the next crucial step in the efforts to prevent dementia at the global level.
U2 - 10.1016/j.lanhl.2024.100665
DO - 10.1016/j.lanhl.2024.100665
M3 - Article
SN - 2666-7568
VL - 5
JO - The Lancet Healthy Longevity
JF - The Lancet Healthy Longevity
IS - 12
M1 - 100665
ER -